University of British Columbia

Category

Prominent New Orleans Physician Discusses Participation in Blaze-1 Study of World’s First Antibody Product Targeting COVID-19

Louisiana’s Ochsner Medical Center in Jefferson Parish is actively contributing its medical, scientific and research talents in the ongoing bid to combat the COVID-19 pandemic. Partnering with industry sponsors such as Eli Lilly, one the health provider’s prestigious...

NYU Langone Among First to Treat COVID-19 Patients with Novel Antibody Arising out of UBC Spinoff Platform & Rapid Lilly Drug Development

NYU Grossman School of Medicine recently began treating patients in a clinical trial to determine whether an antibody therapy known as LY-CoV555 can safely reduce COVID-19 severity. Sponsored by Eli Lilly and Company, this experimental treatment consists of...

B.C. Research Focuses on Managing Immune Response in Critically ill COVID-19 Patients

British Columbia (B.C.) physicians and scientists are learning more about the links between the body’s immune system and the new coronavirus after the recovery of a 32-year-old who nearly died from acute COVID-19. Physicians and researchers at Vancouver General...

UBC & Vancouver General Hospital Lead AWS-Powered AI Initiative for Superior COVID-19 Diagnosis

An artificial intelligence study led by Vancouver clinical physicians and researchers gains momentum as they combine thousands of chest images of COVID-19 patients from around the world. By collecting thousands of CT scans and X-rays from all corners of the globe...

WHO’s COVID-19 SOLIDARITY Trial Lands in Canada & Led by Sunnybrook Health Sciences Centre

The World Health Organization’s (WHO) SOLIDARITY Trial has commenced in Canada as up to 20 participating hospitals gear up for first patient first visit. The study, supported by the Canadian Institutes of Health Research (CIHR), reflects an unprecedented level of...

Pin It on Pinterest